Heroin Dependence, Opioid-Related Disorders
Conditions
Keywords
Interactive Voice Response, Computer-based Treatment, Opioid Agonist, Buprenorphine, Methadone
Brief summary
The purpose of this study is to evaluate the whether an automated telephone-based system is useful and helpful for opioid dependent patients receiving buprenorphine in primary care. The Recovery Line support system is a Therapeutic Interactive Voice Response system based on cognitive behavioral therapy (CBT). The Recovery Line support system includes a variety of modules presenting the basic principles and strategies of CBT. Each module includes learning sections and activities sections to provide direct guidance in using skills. The Recovery Line support system is interactive and also includes a questionnaire to help patients identify problems and recommend modules for use, as well as an inspiration section, an introduction, and an immediate assistance menu. Following development of an initial system the current trial will recruit 40 patients receiving buprenorphine maintenance from a physician provider in the local community. Patients will be randomly (flip of a coin) to receive the Recover Line Support system or to treatment as usual with their physician. Patients assigned to TIVR will be trained on the system and provided 24-hr access to the TIVR system for a four week period. Primary outcome variables will be how long patients remain in treatment, self-reported abstinence from opioids and other drugs, and abstinence as measured by weekly drug screens. It is expected that patients assigned to TIVR will better treatment outcomes than patients assigned to TAU.
Interventions
BEHAVIORALRecovery Line Support System
Full time access (24 hours/7 days per week) to an automated, telephone-based, interactive, voice response (IVR)system for 4 weeks. The program was developed based on a behavioral theory of substance abuse, and comprises four components: 1) self-assessment 2) learning about skills , 3) activities for current help and skills training, and 4) Feedback.
Sponsors
National Institute on Drug Abuse (NIDA)
Yale University
Study design
Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
NONE
Eligibility
Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No
Inclusion criteria
* are at least 18 years old * have initiated buprenorphine maintenance treatment from an approved physician in the previous two weeks
Exclusion criteria
* are a current suicide or homicide risk or meet criteria for psychiatric disorder that would interfere with ability to complete study * are unable to read or understand English * have a life-threatening or unstable medical problem
Design outcomes
Primary
| Measure | Time frame | Description |
|---|---|---|
| Opioid Abstinence | 4 Weeks | Continuous opioid abstinence as documented by weekly urinalysis |
| Retention | 4 Weeks | Retention in the study |
Secondary
| Measure | Time frame | Description |
|---|---|---|
| Self Reported Drug Abstinent | 4 weeks | Drug Abstinence based on weekly interviews |
| system use | 4 weeks | Call total amount, frequency, and specific system utilization |
Countries
United States
Outcome results
None listed